数智重构健康生态，方舟云康以“AI+H2H”模式开辟慢病管理新路径

Core Viewpoint - The integration of artificial intelligence with the healthcare industry is driving a significant transformation in the internet medical sector, with Ark Cloud Health Holdings Limited (referred to as Ark Cloud) leading the way in developing a comprehensive, intelligent chronic disease management ecosystem [1] Group 1: Company Strategy and Innovation - Ark Cloud is positioned as a leading "AI + chronic disease management" service platform, leveraging a forward-looking strategic layout to enhance its competitive edge [1] - The company is innovatively creating an "H2H (Hospital To Home) smart medical ecosystem," which will be fully upgraded to an "AI + H2H smart medical new ecosystem" by 2025, facilitating the deep integration of AI technology throughout the chronic disease management process [1] - The platform has achieved a high repurchase rate of 85.4% among paid users, indicating strong customer loyalty and trust [1] Group 2: Technological Advancements and Applications - Ark Cloud's continuous technological breakthroughs align with both the company's development needs and the market's expectations for the deep integration of "AI + healthcare" [2] - The "AI Health Steward" application exemplifies the practical application of technology, providing users with 24/7 intelligent services and personalized health guidance based on user interactions [2] Group 3: Industry Collaboration and Future Outlook - The company has established strategic partnerships with leading global pharmaceutical companies such as Novo Nordisk, Innovent Biologics, and Huilun Pharmaceutical, creating a synergistic model of "AI + innovative products + refined services" for chronic disease management [3] - Ark Cloud is actively involved in collaborative innovation in academia and industry, participating in national scientific research projects and establishing talent cultivation bases with universities to strengthen its foundation for technological innovation [3] - Looking ahead, Ark Cloud aims to deepen the application of "AI + chronic disease management" across various scenarios and expand its service boundaries, contributing to the "Healthy China 2030" strategic goal [3]